{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:46:59Z","timestamp":1759333619959},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,1,1]]},"DOI":"10.1038\/sj.bmt.1702746","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:48:45Z","timestamp":1031154525000},"page":"85-87","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Atypical chronic graft-versus-host disease following interferon therapy for chronic myeloid leukaemia relapsing after allogeneic BMT"],"prefix":"10.1038","volume":"27","author":[{"given":"J","family":"Serrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Mazarbeitia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Llamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JF","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,1,15]]},"reference":[{"key":"BF1702746_CR1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schatterberg A, Goldman JM et al. Graft-versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041\u20132050","journal-title":"Blood"},{"key":"BF1702746_CR2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","volume":"86","author":"S Mackinnon","year":"1995","unstructured":"Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood 1995 86: 1261\u20131268","journal-title":"Blood"},{"key":"BF1702746_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/sj.bmt.1700762","volume":"19","author":"A Bacigalupo","year":"1997","unstructured":"Bacigalupo A, Soraco M, Vassalto F et al. Donor lymphocyte infusions in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 927\u2013932","journal-title":"Bone Marrow Transplant"},{"key":"BF1702746_CR4","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1182\/blood.V82.10.3211.3211","volume":"82","author":"W Arcese","year":"1993","unstructured":"Arcese W, Goldman JM, D'Arcangelo E et al. Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia Blood 1993 82: 3211\u20133219","journal-title":"Blood"},{"key":"BF1702746_CR5","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V90.7.2549","volume":"90","author":"CS Higano","year":"1997","unstructured":"Higano CS, Chielens D, Raskind W et al. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation Blood 1997 90: 2549\u20132554","journal-title":"Blood"},{"key":"BF1702746_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.bmt.1701607","volume":"23","author":"JL Steegmann","year":"1999","unstructured":"Steegmann JL, Casado LF, Tomas JF et al. Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation Bone Marrow Transplant 1999 23: 483\u2013488","journal-title":"Bone Marrow Transplant"},{"key":"BF1702746_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204\u2013217","journal-title":"Am J Med"},{"key":"BF1702746_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/sj.bmt.1700894","volume":"20","author":"J S\u00e1nchez","year":"1997","unstructured":"S\u00e1nchez J, Torres A, Serrano J et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation Bone Marrrow Transplant 1997 20: 403\u2013408","journal-title":"Bone Marrrow Transplant"},{"key":"BF1702746_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0190-9622(93)70187-X","volume":"29","author":"JS Beard","year":"1993","unstructured":"Beard JS, Smith KL, Skelton HG . Combination chemotherapy with 5-fluorouracil, folinic acid and alpha-interferon producing histological features of graft-versus-host disease J Am Acad Dermatol 1993 29: 325\u2013330","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"BF1702746_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.bmt.1700845","volume":"20","author":"SH Lim","year":"1997","unstructured":"Cyclosporin A\/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplantation for chronic myeloid leukemia: a clinico-pathological study Bone Marrow Transplant 1997 20: 83\u201385","journal-title":"Bone Marrow Transplantation"},{"key":"BF1702746_CR11","first-page":"477","volume":"10","author":"S Pavord","year":"1992","unstructured":"Pavord S, Sivakumaran M, Durrant S, Chapman C . The role of alpha interferon in the pathogenesis of GVHD Bone Marrow Transplant 1992 10: 477","journal-title":"Bone Marrow Transplant"},{"key":"BF1702746_CR12","first-page":"641","volume":"24","author":"PJ Browett","year":"1994","unstructured":"Browett PJ, Nelson J, Tiwari S et al. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukemia post-allogeneic bone marrow transplantation Bone Marrow Transplant 1994 24: 641\u2013644","journal-title":"Bone Marrow Transplant"},{"key":"BF1702746_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.bmt.1700859","volume":"20","author":"J Metha","year":"1997","unstructured":"Metha J, Powles R, Kulkarni S et al. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients Bone Marrow Transplant 1997 20: 129\u2013135","journal-title":"Bone Marrow Transplant"},{"key":"BF1702746_CR14","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1182\/blood.V78.12.3306.3306","volume":"78","author":"HG Klingemann","year":"1991","unstructured":"Klingemann HG, Grigg AP, Wilkie-Boyd K et al. Treatment with recombinant interferon (\u03b1-2b) early after bone marrow transplantation in patients at high risk for relapse Blood 1991 78: 3306\u20133311","journal-title":"Blood"},{"key":"BF1702746_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","volume":"25","author":"T Okanoue","year":"1996","unstructured":"Okanoue T, Sakamoto S, Itoh Y et al. Side effects of high-dose interferon therapy for chronic hepatitis C J Hepatol 1996 25: 283\u2013291","journal-title":"J Hepatol"},{"key":"BF1702746_CR16","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1084\/jem.162.5.1645","volume":"162","author":"MG Skoskiewicz","year":"1985","unstructured":"Skoskiewicz MG, Colvin RB, Schneerburger EE, Russell PS . Histocompatibility complex-determined antigens in vivo by gamma interferon J Exp Med 1985 162: 1645\u20131664","journal-title":"J Exp Med"},{"key":"BF1702746_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00007890-198708000-00017","volume":"44","author":"T Ghayur","year":"1987","unstructured":"Ghayur T, Seemayer TA, Kongshavn PA et al. Graft versus host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease Transplantation 1987 44: 261\u2013267","journal-title":"Transplantation"},{"key":"BF1702746_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/00007890-198703000-00018","volume":"43","author":"VE Reyes","year":"1987","unstructured":"Reyes VE, Klimpel GR . Interferon alpha\/beta synthesis during acute graft versus host disease Transplantation 1987 43: 412\u2013416","journal-title":"Transplantation"},{"key":"BF1702746_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0008-8749(87)90106-7","volume":"110","author":"MG Cleveland","year":"1987","unstructured":"Cleveland MG, Lane RG, Klimpel GR . Enhaced interferon alpha\/beta and defective interferon gamma production in chronic graft-versus-host disease: a potential mechanism for immunosuppression Cell Immunol 1987 110: 120\u2013130","journal-title":"Cell Immunol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702746","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:11:05Z","timestamp":1648073465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1,1]]}},"alternative-id":["BF1702746"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702746","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1,1]]},"assertion":[{"value":"23 March 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}